These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 19833483)
21. Short-term prospective comparison of prepulse inhibition between schizophrenic patients and healthy controls. Preuss UW; Zimmermann J; Watzke S; Langosch J; Siafarikas N; Wong JW; Hamm A; Weike A Pharmacopsychiatry; 2011 May; 44(3):102-8. PubMed ID: 21432751 [TBL] [Abstract][Full Text] [Related]
22. A follow-up study on features of sensory gating P50 in treatment-resistant depression patients. Wang Y; Fang YR; Chen XS; Chen J; Wu ZG; Yuan CM; Yi ZH; Hong W; Zhang C; Cao L Chin Med J (Engl); 2009 Dec; 122(24):2956-60. PubMed ID: 20137481 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of subjective treatment satisfaction with antipsychotics in schizophrenia patients. Fujikawa M; Togo T; Yoshimi A; Fujita J; Nomoto M; Kamijo A; Amagai T; Uchikado H; Katsuse O; Hosojima H; Sakura Y; Furusho R; Suda A; Yamaguchi T; Hori T; Kamada A; Kondo T; Ito M; Odawara T; Hirayasu Y Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):755-60. PubMed ID: 18226436 [TBL] [Abstract][Full Text] [Related]
24. Effects of nicotine on the amplitude and gating of the auditory P50 and its influence by dopamine D2 receptor gene polymorphism. Knott V; Millar A; Fisher D; Albert P Neuroscience; 2010 Mar; 166(1):145-56. PubMed ID: 19961902 [TBL] [Abstract][Full Text] [Related]
25. Auditory verbal hallucinations in schizophrenia correlate with P50 gating. Smith DM; Grant B; Fisher DJ; Borracci G; Labelle A; Knott VJ Clin Neurophysiol; 2013 Jul; 124(7):1329-35. PubMed ID: 23490551 [TBL] [Abstract][Full Text] [Related]
26. Differential sensory gating functions between smokers and non-smokers among drug-naive first episode schizophrenic patients. Chen XS; Li CB; Smith RC; Xiao ZP; Wang JJ Psychiatry Res; 2011 Aug; 188(3):327-33. PubMed ID: 21216472 [TBL] [Abstract][Full Text] [Related]
27. Olanzapine effects on auditory sensory gating in schizophrenia. Arango C; Summerfelt A; Buchanan RW Am J Psychiatry; 2003 Nov; 160(11):2066-8. PubMed ID: 14594761 [TBL] [Abstract][Full Text] [Related]
28. P50 suppression and its neural generators in antipsychotic-naive first-episode schizophrenia before and after 6 months of quetiapine treatment. Oranje B; Aggernaes B; Rasmussen H; Ebdrup BH; Glenthøj BY Schizophr Bull; 2013 Mar; 39(2):472-80. PubMed ID: 22241164 [TBL] [Abstract][Full Text] [Related]
29. Differential effects of nicotine on P50 amplitude, its gating, and their neural sources in low and high suppressors. Knott VJ; Fisher DJ; Millar AM Neuroscience; 2010 Oct; 170(3):816-26. PubMed ID: 20643194 [TBL] [Abstract][Full Text] [Related]
30. Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). Jones PB; Barnes TR; Davies L; Dunn G; Lloyd H; Hayhurst KP; Murray RM; Markwick A; Lewis SW Arch Gen Psychiatry; 2006 Oct; 63(10):1079-87. PubMed ID: 17015810 [TBL] [Abstract][Full Text] [Related]
31. [The follow-up study on P50 auditory sensory gating in naïve schizophrenia]. Wang HX; Zhang MD; Wang ZC; Chen XS; Lou FY; Liang JH; Chen C Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(9):601-5. PubMed ID: 20450782 [TBL] [Abstract][Full Text] [Related]
32. P50 suppression, prepulse inhibition, and startle reactivity in the same patient cohort suffering from posttraumatic stress disorder. Holstein DH; Vollenweider FX; Jäncke L; Schopper C; Csomor PA J Affect Disord; 2010 Oct; 126(1-2):188-97. PubMed ID: 20347156 [TBL] [Abstract][Full Text] [Related]
34. The effects of sertindole on sensory gating, sensorimotor gating, and cognition in healthy volunteers. Holstein DH; Csomor PA; Geyer MA; Huber T; Brugger N; Studerus E; Vollenweider FX J Psychopharmacol; 2011 Dec; 25(12):1600-13. PubMed ID: 21890590 [TBL] [Abstract][Full Text] [Related]
35. Sensory gating and source analysis of the auditory P50 in low and high suppressors. Knott V; Millar A; Fisher D Neuroimage; 2009 Feb; 44(3):992-1000. PubMed ID: 19007892 [TBL] [Abstract][Full Text] [Related]
36. Impaired P50 sensory gating in post-traumatic stress disorder secondary to urban violence. Ghisolfi ES; Margis R; Becker J; Zanardo AP; Strimitzer IM; Lara DR Int J Psychophysiol; 2004 Feb; 51(3):209-14. PubMed ID: 14962572 [TBL] [Abstract][Full Text] [Related]
37. A meta-analysis of the efficacy of second-generation antipsychotics. Davis JM; Chen N; Glick ID Arch Gen Psychiatry; 2003 Jun; 60(6):553-64. PubMed ID: 12796218 [TBL] [Abstract][Full Text] [Related]
38. Effects of phencyclidine on auditory gating in the rat hippocampus and the medial prefrontal cortex. Dissanayake DW; Zachariou M; Marsden CA; Mason R Brain Res; 2009 Nov; 1298():153-60. PubMed ID: 19699183 [TBL] [Abstract][Full Text] [Related]
39. The effects of chronic administration of established and putative antipsychotics on natural prepulse inhibition deficits in Brattleboro rats. Feifel D; Melendez G; Priebe K; Shilling PD Behav Brain Res; 2007 Aug; 181(2):278-86. PubMed ID: 17559953 [TBL] [Abstract][Full Text] [Related]
40. The P50 midlatency auditory evoked potential in patients with chronic low back pain (CLBP). Fann AV; Preston MA; Bray P; Mamiya N; Williams DK; Skinner RD; Garcia-Rill E Clin Neurophysiol; 2005 Mar; 116(3):681-9. PubMed ID: 15721082 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]